Lv4
475 积分 2020-08-08 加入
THR-β agonism in MASH: expanding the evidence to Asia
4天前
求助中
THR-β agonism in MASH: expanding the evidence to Asia
5天前
已关闭
Clinical utility of a 30% reduction in VCTE-derived liver stiffness measurement for identifying histologic improvement in MASH
10天前
已完结
International expert panel review for the use of resmetirom and semaglutide in the management of MASH-related fibrosis: clinical practice update
1个月前
已完结
On-demand transarterial chemoembolisation combined with atezolizumab and bevacizumab in patients with untreated hepatocellular carcinoma (TALENTACE): a multicentre, randomised, open-label, phase 3 trial
1个月前
已完结
DiabetesLiver score: A non-invasive algorithm for advanced liver fibrosis and liver-related outcomes in type 2 diabetes mellitus population
2个月前
已完结
Glecaprevir-pibrentasvir to treat chronic hepatitis C virus infection in Asia: two multicentre, phase 3 studies- a randomised, double-blind study (VOYAGE-1) and an open-label, single-arm study (VOYAGE-2)
2个月前
已完结
Renin-angiotensin-aldosterone system inhibitor use improves clinical outcomes in patients with metabolic dysfunction-associated steatotic liver diseases: Target trial emulation using real-world data
3个月前
已完结
Fat Distribution Within the Pancreas According to Diabetes Status and Insulin Traits
5个月前
已完结
qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis
6个月前
已完结
皖公网安备34019202002308
